Back
Perspective Therapeutics Stock Price Chart
Sponsored
CATX
Sponsored
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
31
CATX
Perspective Therapeutics
Last Price:
13.55
Seasonality Move:
-10.19%
7 Day Trial
ALL ACCESS PASS
$
7
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.
Perspective Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.73 | Sell |
20-day SMA: | 15.07 | Sell |
50-day SMA: | 13.7 | Sell |
200-day SMA: | 11.22 | Buy |
8-day EMA: | 14.29 | Sell |
20-day EMA: | 14.54 | Sell |
50-day EMA: | 13.97 | Sell |
200-day EMA: | 11.48 | Buy |
Perspective Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.08 | Buy |
Relative Strength Index (14 RSI): | 41.91 | Sell |
Chaikin Money Flow: | -533654 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.94 - 15.76) | Sell |
Bollinger Bands (100): | (11.54 - 15.98) | Sell |
Perspective Therapeutics Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Perspective Therapeutics Stock
Is Perspective Therapeutics Stock a Buy?
- Perspective Therapeutics share price is 13.35 while CATX 8-day simple moving average is 14.73, which is a Sell signal.
- The stock price of CATX is 13.35 while Perspective Therapeutics 20-day SMA is 15.07, which makes it a Sell.
- Perspective Therapeutics 50-day simple moving average is 13.70 while CATX share price is 13.35, making it a Sell technically.
- CATX stock price is 13.35 and Perspective Therapeutics 200-day simple moving average is 11.22, creating a Buy signal.
CATX Technical Analysis vs Fundamental Analysis
Sell
31
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy or a Sell?
-
Perspective Therapeutics stock is rated a Sell
The current Perspective Therapeutics [CATX] share price is $13.35. The Score for CATX is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
Perspective Therapeutics Stock Info
Market Cap:
900.16M
Price in USD:
13.35
Share Volume:
664.73K
Perspective Therapeutics 52-Week Range
52-Week High:
19.05
52-Week Low:
2.20
Sell
31
Perspective Therapeutics (CATX)
is a Sell
Perspective Therapeutics Share Price Forecast
-
What is the Perspective Therapeutics stock price today?
The Perspective Therapeutics stock price is 13.35 USD today. -
Will CATX stock go up or go down?
Perspective Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Perspective Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Perspective Therapeutics is overvalued.
Is Perspective Therapeutics Stock a Buy?
- Perspective Therapeutics share price is 13.35 while CATX 8-day exponential moving average is 14.29, which is a Sell signal.
- The stock price of CATX is 13.35 while Perspective Therapeutics 20-day EMA is 14.54, which makes it a Sell.
- Perspective Therapeutics 50-day exponential moving average is 13.97 while CATX share price is 13.35, making it a Sell technically.
- CATX stock price is 13.35 and Perspective Therapeutics 200-day simple moving average is 11.48, creating a Buy signal.
Fundamental Analysis of Perspective Therapeutics
Is Perspective Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.08 per share.
Technical Analysis of Perspective Therapeutics
Should I short Perspective Therapeutics stock?
- CATX Moving Average Covergence Divergence (MACD) indicator is 0.08, suggesting Perspective Therapeutics is a Buy
- Perspective Therapeutics Relative Strength Index (RSI) is 41.91, which suggest Perspective Therapeutics is oversold
- The Bollinger Bands (25) for Perspective Therapeutics is (13.94 - 15.76), which suggest Perspective Therapeutics is a Sell
- The Bollinger Bands (100) for Perspective Therapeutics is (11.54 - 15.98), which suggest Perspective Therapeutics is a Sell
* Perspective Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.